APA (7th ed.) Citation

CD, H., J, N., L, M., AE, P., RT, W., C, S., . . . B, K. (2023). Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin-4/13 Inhibitor. Arthritis & rheumatology (Hoboken, N.J.), 75(10), 1793. https://doi.org/10.1002/art.42558

Chicago Style (17th ed.) Citation

CD, Hughes, Nathan J, Mathew L, Pink AE, Woolf RT, Smith C, Menon B, and Kirkham B. "Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin-4/13 Inhibitor." Arthritis & Rheumatology (Hoboken, N.J.) 75, no. 10 (2023): 1793. https://doi.org/10.1002/art.42558.

MLA (9th ed.) Citation

CD, Hughes, et al. "Characterization of a Musculoskeletal Syndrome of Enthesitis and Arthritis in Patients With Atopic Dermatitis Treated With Dupilumab, an Interleukin-4/13 Inhibitor." Arthritis & Rheumatology (Hoboken, N.J.), vol. 75, no. 10, 2023, p. 1793, https://doi.org/10.1002/art.42558.